Shijiazhuang Yiling Pharmaceutical Co., Ltd
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Shijiazhuang Yiling Pharmaceutical Co., Ltd
The role of a traditional Chinese medicine provided to the general public in China to fend off COVID-19 is controversial given limited evidence and even misleading, some say.
As Shanghai enters a second week of a city-wide lockdown with no signs of policy easing, officials are promoting the use of traditional Chinese medicines rather than Pfizer's recently approved Paxlovid.
Private Company Edition: The astonishing pace of venture capital investment in drug development continues with another $1.5bn in financings of $100m or more, including $152m for Pyxis and $126m for Omega. New VC funds also continue to launch, including RiverVest’s fifth fund, totaling $275m.
Genosis Ltd. is developing both male and female fertility tests, which couples can use at home to help identify reproductive disorders at an earlier stage, allowing those who need in vitro fertilization to progress onto it more quickly, with better results.
- Generic Drugs